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Background: To clarify the direction of the association between frequency of cannabis use, 
depressive symptoms and suicidal ideation from 15 to 20 years using cross-lagged analyses.  
Method: We included 1606 adolescents from the province of Québec followed since 1997 with 
information on frequency of cannabis use (none/monthly/weekly), depression (defined as being 
in the top 10% symptoms) and serious suicidal ideation at ages 15, 17 and 20 years.  
Results: The prevalence of weekly cannabis use increased from 7.0% at age 15 years to 15.6% 
by age 20 years. Adolescents who reported using cannabis weekly at one age were 11 to 15 times 
more likely to continue using cannabis over time. In longitudinal cross-lagged analyses, weekly 
cannabis use at age 15 was associated with greater odds (OR:2.19, 95% CI:1.04-4.58) of suicidal 
ideation two years later. However, other substance use (alcohol, tobacco, other drugs) fully 
explained this association. Further, depression predicted subsequent weekly cannabis use, even 
after adjusting for comorbid other substance use (eg, for depression at 15 years predicting 
cannabis use at 17 years: OR:2.30, 95% CI:1.19-4.43).  
Limitations: Quantity of cannabis consumed was not measured. 
Conclusion: Findings suggest that depressive symptoms in adolescence may represent a risk 
factor for weekly cannabis consumption, which once initiated is likely to remain chronic. 
Weekly cannabis use increased risk for suicidal ideation, but not independently from other 
substance use including alcohol, tobacco and other drugs. 






Cannabis is one of the most widely used psychoactive substances around the world 
(Degenhardt et al., 2013b) and its legalization in Canada and many states in the USA has raised 
concerns about its associations with mental health. Recent reviews and meta-analyses in adult 
populations suggest that cannabis use may be associated with depression and suicidal ideation 
(Borges et al., 2016; Lev-Ran and Feingold, 2017; Lev-Ran et al., 2014). However, our 
knowledge on associations between cannabis use and mental health in young people is more 
limited. Youths aged 15 to 24 years have the highest rates of mood disorders and suicidal 
ideation across the lifespan (Kessler et al., 2005; Nock et al., 2008), and represent the largest 
group of cannabis consumers worldwide (Degenhardt et al., 2016; Poulton et al., 1997), making 
adolescence a period of heightened vulnerability for comorbid mental health and substance use 
problems.  
Adolescent cannabis use has been associated with depression and suicidal ideation cross-
sectionally. For instance, prior studies have reported associations between the extent of cannabis 
consumption (ranging from any to heavy consumption) and higher odds of depression (odds ratio 
(ORs) ranging from 1.20 to 1.65) (Degenhardt et al., 2013a; Poulin et al., 2005b; Rasic et al., 
2013; Rey et al., 2002) and suicidal ideation (ORs:1.30 to 2.45) (Carvalho et al., 2019; Huas et 
al., 2008; Sellers et al., 2019; Swahn et al., 2012). However, in cross-sectional studies, it is not 
possible to ascertain the developmental sequence of association; i.e., cannabis use preceding 
depression/suicidal ideation (secondary psychiatric disorder hypothesis) (Gobbi et al., 2019; 
Poorolajal et al., 2016) or depression/suicidal ideation preceding cannabis use (secondary 
substance use hypothesis) (Khantzian, 1987).  
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 A recent meta-analysis of longitudinal studies (k=13) reported that weekly adolescent 
cannabis users were at increased odds for depression diagnosis and suicidal ideation and attempt 
in young adulthood (Gobbi et al., 2019), consistent with previous findings from large 
representative samples of youth (Fergusson et al., 2002; Silins et al., 2014). However, not all of 
the included studies in the meta-analysis adjusted for other substance use, including alcohol, 
despite its important overlap with cannabis use (Leatherdale and Burkhalter, 2012), and its 
associations with depression and suicidal ideation (Brière et al., 2014; Marschall-Lévesque et al., 
2017; Poorolajal et al., 2016). Furthermore, their outcomes were assessed during young 
adulthood making it difficult to ascertain if acute effects of cannabis are detectable during 
adolescence. The investigation of such outcomes during adolescence are warranted given that the 
initiation of substance use typically occurs during this developmental period (Dick et al., 2000; 
Martin et al., 2002), with an increased risk of overall substance use peaking around mid-to-late 
adolescence (Patton et al., 2004).  
Only few longitudinal studies have investigated the increased risk of cannabis use among 
youth with prior depression and/or suicidal ideation. Such studies have demonstrated that 
depression and suicidal ideation are associated with subsequent cannabis use (Rhew et al., 2017; 
Weinberger et al., 2020; Zhang and Wu, 2014), but most were based on small unrepresentative 
samples of adolescents (Rhew et al., 2017) and relied on a broad measure of cannabis use (ie, 
any or none) (Weinberger et al., 2020; Zhang and Wu, 2014). Therefore, there is a need to clarify 
the longitudinal associations between cannabis use, depression and suicidal ideation by assessing 
the bidirectionality of these associations. 
The few studies that have investigated the bidirectional associations between cannabis 
use and depression in adolescence and/or young adulthood simultaneously (Hoffmann, 2018; 
 7 
Wilkinson et al., 2016; Womack et al., 2016) have been limited by small unrepresentative 
samples (Hoffmann, 2018; Womack et al., 2016), with only one longitudinal study based on a 
representative sample (Wilkinson et al., 2016). Using data from the National Longitudinal Study 
of Adolescent to Adult Health in the US (data collection spanned from 1994 to 2009), this study 
supported an association from depressive symptoms to later cannabis use in both males and 
females from adolescence to young adulthood, but not from cannabis use to depressive 
symptoms (Wilkinson et al., 2016). However,  given that the prevalence of cannabis 
consumption (Johnston et al., 2019), depression (Mojtabai et al., 2016), and suicidal ideation 
(Burstein et al., 2019) in adolescents has increased since then, it is important to study these 
associations in today’s generations of adolescents. Further, to our knowledge, no prior 
longitudinal study has examined bidirectional associations between cannabis use and suicidal 
ideation.  
Using data from a representative cohort of Canadian youth, we investigated the 
developmental sequence of association between cannabis use, depression and suicidal ideation 
from 15 to 20 years, using cross-lagged models, to allow for the simultaneous investigation of 
bidirectional associations.  
Method 
Participants 
Participants were from the Québec Longitudinal Study of Child Development (QLSCD), 
conducted by the Institut de la statistique du Québec (ISQ; Québec Statistics Institute), which is a 
population-based cohort of 2120 individuals born in the Canadian province of Québec in 
1997/98 who were followed up until 20 years of age. The original sample was selected from the 
Québec birth registry using a stratified procedure based on living area and birth rate. Single-birth 
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children were included if the mother could speak English or French. Data were collected 
annually or biannually from 1998 through 2018. For more details about the larger study design, 
please see: http://www.iamillbe.stat.gouv.qc.ca. 
In the present study, we included 1606 participants who completed a confidential online 
questionnaire and for whom data were available at 15, 17 and 20 years, accounting for 76% of 
the original cohort. To account for attrition, we conducted analyses with inverse probability 
weights, where weights represented participants’ probabilities of being included in the study 
sample conditional on variables related to attrition: males (39.5% v. 47.9%); internalizing 
behaviors in childhood (M=1.11 v. M=1.32); mothers with lower education (22.6% v.16.8%); 
and families with a single parent (11.1% v. 7.1%) (See supplementary Table 1).  
Ethical Considerations  
The QLSCD was approved by the Québec Statistics Institute and the St-Justine Hospital 
Research Center ethics committees, and informed consent was obtained at each data collection. 
Measures at 15, 17 and 20 years 
Cannabis Use  
Cannabis use in the past-year was assessed using the following item: “During the past 12 
months, how often did you use cannabis (marijuana/pot/hashish)?” Responses ranging from “I 
didn’t” (1) to “everyday” (7) were grouped into three categories: Non-users, Monthly Users (1x 
to try/<1x/month/about1x/month), Weekly Users (1-2x/week/≥3x/week/everyday).  
Depression 
Depressive symptoms were self-reported by adolescents at ages 15 and 17 years using the 
Mental Health and Social Inadaptation Assessment (MIA) (Côté et al., 2017), and at 20 years 
using the Centre for Epidemiological Studies Depression Scale (CES-D) (Poulin et al., 2005a; 
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Radloff, 1977); see Appendix for a full list of items used. The MIA depression subscale consists 
of eight symptoms in the past year (eg, “I lost interest in things I usually like,” α=.87 and .88 at 
ages 15 and 17 years, respectively); scored as 0 (never true), 1 (sometimes true) or 2 (often true). 
The CES-D short version (Poulin et al., 2005a) contains 12 items assessing symptoms that 
occurred in the past week (eg, “I felt depressed,” α=.77) with response options ranging from 0 to 
3. Adolescents in the top 10% of symptoms were identified as having elevated symptoms, which 
we refer to as depression and all models were also estimated using depressive symptoms treated 
as a continuous variable.  
Suicidal ideation  
We measured past year suicidal ideation  (Côté et al., 2017; Geoffroy et al., 2016) with 
the following question, “Did you ever seriously think of attempting suicide?” Coded as no versus 
yes for serious suicidal ideation. 
Other Substance Use (alcohol, tobacco and other drugs) 
At each age, adolescents reported on their past-year other substance use in terms of: 
consuming alcohol (non-users/monthly users (<two drinks/week)/weekly users (≥two 
drinks/week); consuming tobacco (i.e., smoking cigarettes) (non-users/monthly/weekly users); 
and other drugs (cocaine/solvents/hallucinogens/heroin/amphetamines/methamphetamines/ 
medication without prescription (yes/no)). 
Statistical Analyses 
We first described the prevalence of cannabis use, depression and suicidal ideation and its 
associations with sex using chi-squared tests based on the maximum available number of cases 
for each variable at ages 15, 17 and 20 years. We then assessed concurrent associations between 
cannabis use and depression and suicidal ideation at each age using cross-tabulations and logistic 
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regressions. Finally, we used structural equation modelling to conduct an integrated cross-lagged 
model examining associations between cannabis use, depression and suicidal ideation across 
three time points using Mplus version 7.4 (Muthén and Muthén, 1998-2015). This type of 
analysis allows examining bidirectional effects between variables, while controlling for their 
stability over time. Regressed effects of cannabis use, depression and suicidal ideation were 
controlled for at ages 15 and 17 years. Given that alcohol, tobacco and other drug use were 
significantly correlated with cannabis use (see supplementary Table 2), they were added as 
baseline covariates at ages 15 and 17 years. Our two hypotheses were nested within the cross-
lagged model allowing for them to be tested simultaneously. The model showed good fit to the 
data (Root Mean Square Error of Approximation=0.043, 90% CI=0.034-0.053; Comparative Fit 
Index=0.929). Full information maximum likelihood was used to handle missing data (Johnson 
and Young, 2011). This procedure was able to estimate the parameters of participants 
contributing to at least one data point (N=1606). Due to lack of statistical power, cross-lagged 
models were only estimated while combining males and females. Depression and suicidal 
ideation were entered simultaneously in the models. Finally, we undertook sensitivity analyses 
and re-estimated the cross-lagged models (a) using a continuous measure of depressive 
symptoms instead of top 10% of symptoms and (b) modeling depression and suicidal ideation 
separately. 
Results 
As shown in Table 1, overall prevalence of weekly cannabis use increased from 7.0% at 
age 15 years to 12.7% at age 17 years and 15.6% at age 20 years. The prevalence of weekly 
cannabis use was higher for males (15.1%-18.4%) compared to females (10.5%-13.5%) at ages 
17 and 20 years, ps<.05. Similar trends were observed for monthly cannabis use. The prevalence 
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of depression was predefined at approximately 10.0%, but varied for males and females, such 
that the prevalence was slightly higher in females (12.9-15.4%) than males (4.2-8.6%) at all 
ages, ps<.05. The prevalence of suicidal ideation also varied by sexes: 8.7–9.1% for females and 
3.1-4.1% for males at ages 15 and 17 years, ps<.05. Cannabis had significant overlap with 
alcohol, tobacco and other drug use at all ages, ps<.001 (see supplementary Table 2). For 
instance, of adolescents using cannabis weekly at age 15 years, 33.7%, 40.6% and 47.0% also 
used alcohol and tobacco weekly and other drugs, respectively.  
Using cross-tabulations and logistic regressions, Table 2 indicated that cannabis use 
was concurrently associated with suicidal ideation and depression. Being a weekly cannabis user 
was associated with suicidal ideation at all ages, with Odds Ratios (ORs) ranging from 2.39 to 
3.83. Similarly, weekly cannabis use was associated with depression at ages 15 and 17 years 
(ORs=2.35 and 2.56 respectively) although not at age 20 years. Patterns of associations were 
similar for monthly cannabis use, although ORs were smaller in magnitude. Interactions with sex 
were investigated by computing an interaction term between sex and cannabis use (non-
user/monthly/weekly) which was entered as a continuous variable. All interactions with sex were 
non-significant (ps>.05); suggesting that concurrent associations did not differ for males and 
females. 
Cross-lagged models are presented in Figures 1 (unadjusted) and 2 (adjusted for sex and 
other substance use at baseline, i.e. 15y and 17y entered as continuous variables in the models). 
Autoregressive effects of depression, suicidal ideation and cannabis use  
Autoregressive effects describe the stability of the measures from one measurement point 
to the next. We found strong stability for all measures from ages 15 to 20 years. For example, 
weekly cannabis use at age 15 years was associated with an increased likelihood to carry this 
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behavior at age 17 years (OR=34.65, 95%CI=19.51-61.56), and subsequently at age 20 years 
(OR=21.01, 95%CI=12.40-35.59; see Figure 1). Additionally, monthly cannabis use was 
associated with weekly cannabis use at later time points: associations tend to be stronger for the 
period from ages 15 to 17 years (OR=6.39, 95%CI= 4.12-9.90; see Figure 1) than for the period 
from ages 17 to 20 years (OR=2.38, 95%CI=1.47-3.86).  
Prediction from cannabis use to subsequent depression and suicidal ideation  
As shown in Figure 1, adolescents who used cannabis weekly at age 15 years were at an 
increased risk of suicidal ideation at 17 years (OR=2.19, 95%CI=1.04-4.58), but not at 20 years 
(OR=0.72, 95%CI=0.15-1.30). However, adjustment for other substance use including alcohol, 
tobacco and other drugs at age 15 years abolished this association (OR=1.38, 95%CI=0.52-3.20; 
see Figure 2). Weekly cannabis use did not increase the risk of depression at ages 17 or 20 years.   
Prediction from depression and suicidal ideation to subsequent cannabis use  
Adolescents with depression at age 15 years were at increased risk of subsequent weekly 
cannabis use at age 17 years, and this association remained after adjusting for sex and other 
substance use (OR=2.30, 95%CI=1.19-4.43, see Figure 2). Moreover, depression at age 15 years 
indirectly increased risk of using cannabis weekly at age 20 years through weekly cannabis use 
at age 17 years (OR=7.55, 95%CI=1.36-42.05). In a further analysis, we adjusted for (in addition 
to sex and other substance use) family socioeconomic status (aggregate of annual gross income, 
parental education level and occupational prestige) (Willms and Shields, 1996) measured at age 
15 years. Associations hardly changed after further adjustment for family socioeconomic status: 
depression at age 15 years was associated with weekly cannabis use at age 17 years (OR=2.41; 
95%CI= 1.25-4.18; see Supplementary Figure 1). Depression at age 17 years was not 
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associated with cannabis use at age 20 years. Suicidal ideation was not associated with later 
cannabis use at any age. 
Sensitivity analyses 
The results were largely similar to those based on a categorical measure using a 
continuous measure of depressive symptoms in the cross-lagged models: (1) Weekly cannabis 
use at ages 15 and 17 years was not associated with greater depressive symptoms later on, and 
(2) Depressive symptoms were associated with later weekly cannabis use at ages 17 (β=0.21, 
95%CI= 0.10-0.31), and 20 (β=0.13, 0.03-0.22) years. Further, patterns of results were similar 
while modeling depression and suicidal ideation separately (data not shown). 
Discussion 
This population-based study is the first, to our knowledge, to examine the temporal 
relation between cannabis use, depression and suicidal ideation simultaneously over five years 
during adolescence. Depression (but not suicidal ideation) predicted weekly cannabis use 
throughout adolescence. Weekly cannabis use predicted suicidal ideation (but not depression), 
but this association was no longer significant after taking into account other substance use 
including alcohol, tobacco and other drugs consumption. Associations observed for adolescents 
experiencing depression (defined as being in the top 10% of symptoms) were similar to those 
observed for the full spectrum of depressive symptoms.  Compared to the few other studies 
(Hoffmann, 2018; Wilkinson et al., 2016; Womack et al., 2016) that have investigated the 
bidirectional associations between depression and cannabis use simultaneously, our study had the 
advantage of also examining suicidal ideation in the cross-lagged models and was based on a 
representative sample of today’s adolescents. 
Interpretation and comparison with other studies   
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Prediction from cannabis use to subsequent depression and suicidal ideation  
In line with previous epidemiological findings (Degenhardt et al., 2013a; Rasic et al., 
2013), the prevalence of weekly cannabis use for adolescents was 15.6% by age 20 years, and 
males were more likely to use cannabis compared to females. Cannabis use was concurrent with 
depression and suicidal ideation in the cohort, consistent with other studies including a Canadian 
cohort (Halladay et al., 2019). As such, it is of major interest to clarify the developmental 
sequence of association between these variables. Two previous longitudinal studies investigating 
bidirectional associations between cannabis use and depression in adolescence reported an 
association from cannabis use to depression (Hoffmann, 2018; Horwood et al., 2012), whereas 
another study failed to detect an association (Womack et al., 2016).  
A previous meta-analysis (Gobbi et al., 2019) of longitudinal studies reported that weekly 
cannabis use predicted depression (OR=1.37) and suicidal ideation (OR=1.50) in young 
adulthood, whereas the association from depression and suicidal ideation to cannabis use was not 
investigated. Our study confirmed that weekly cannabis users had two times the odds of suicidal 
ideation at age 17 years only (but not depression) compared to non-cannabis users.  
The specific association of cannabis use with suicidal ideation, but not depression, also 
contrasts with prior studies in adult populations showing increased risk of depression consecutive 
to cannabis use (Agrawal et al., 2017; Lev-Ran et al., 2014; Smolkina et al., 2017). In one study, 
initiation of cannabis before the age of 17 years was associated with depression in monozygotic 
twins discordant for cannabis use (Agrawal et al., 2017). It has also been documented that 
persistent and chronic cannabis use throughout adolescence is associated with depression later on 
(Horwood et al., 2012; Patton et al., 2002; Thompson et al., 2018). It could be that the 
consequences of cannabis use on mental health become apparent only after a certain duration of 
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using cannabis (Masten and Cicchetti, 2010). Comparatively, findings from the Dunedin 
Multidisciplinary Health and Development Study (McGee et al., 2000) demonstrated that 
cannabis use was associated with depression  in young adulthood, but not during adolescence.   
These results shed light on the possibility that cannabis use may increase depression under 
certain conditions, such as an early age of onset or after a certain chronicity of use.  
Similar to other studies (Tomczyk et al., 2016), we found that a large number of weekly 
cannabis users simultaneously use other drugs including, but not limited to, cocaine, 
hallucinogens and amphetamines, and consume alcohol and tobacco on a frequent basis. In our 
study, the association from weekly cannabis use to suicidal ideation was better explained by 
other substance use (alcohol, tobacco and other drugs) being associated with suicidal ideation in 
adolescence (Darvishi et al., 2015; Marschall-Lévesque et al., 2017; Poorolajal et al., 2016). This 
suggests that it may be other substance use (alone or in combination with cannabis use), rather 
than cannabis use alone, that increases the risk of suicidal ideation (Rasic et al., 2013). Prior 
studies included in the meta-analysis did not control for comorbid substance use (Gobbi et al., 
2019). Further, their outcome measures of depression and suicidal ideation were measured in 
young adulthood (Gobbi et al., 2019), whereas our study measured these outcomes throughout 
adolescence.  
Prediction from depression and suicidal ideation to subsequent cannabis use  
 As far as we are aware very few longitudinal studies have investigated associations from 
depression to cannabis use (Hoffmann, 2018; Hooshmand et al., 2012; Rhew et al., 2017; 
Wilkinson et al., 2016; Womack et al., 2016) and from suicidal ideation to cannabis use (Zhang 
and Wu, 2014). All studies (except (Hoffmann, 2018)) demonstrated that depression and suicidal 
ideation were associated with increased subsequent cannabis use during adolescence. Our study 
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extends the current body of knowledge by showing that today’s adolescents experiencing 
depression were at an increased risk of using cannabis weekly, within cross-lagged models.  
The associations in our study were also apparent while considering depressive symptoms 
instead of the top 10% of symptoms, suggesting that risk of using cannabis weekly is seen for the 
full spectrum of depressive symptoms. Further, our study demonstrated that depression at age 15 
years indirectly increased the risk of using cannabis weekly at age 20 years through its 
association with weekly cannabis use at age 17 years. 
Such associations from depression to cannabis use are in line with the secondary 
substance use hypothesis which posits that depression precedes cannabis use, whereby 
adolescents may use cannabis to alleviate distress (Khantzian, 1987). Specifically, cannabis has 
the ability to reduce negative mood states that exist prior to its use, but it does not resolve the 
underlying mood disturbances (Johns, 2001). As such, cannabis use may become reinforcing for 
vulnerable adolescents experiencing depression, as its ability to propagate euphoric mood states 
may be interpreted as therapeutic by the adolescent, where in fact the use of cannabis actually 
increases their vulnerability to substance use (Borodovsky and Budney, 2018).  
Overall, about 16% of the adolescents in this study were weekly cannabis users by age 20 
years, compared to 7% at age 15 years, suggesting that cannabis use increases throughout 
adolescence. Further, adolescents who used cannabis weekly and monthly were at heightened 
risk to use cannabis weekly later on, as shown elsewhere (Caldeira et al., 2012; Homel et al., 
2014; Schulenberg et al., 2005).  
Strengths and Limitations  
This study relied on a large representative cohort of today’s youth with repeated 
measurements of cannabis use, depression and suicidal ideation collected in 2013 (15 years), 
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2015 (17 years) and 2018 (20 years), which allowed for the modelling of all associations 
simultaneously. However, our study had some limitations. First, self-reported frequency of 
cannabis use may have been subject to response bias (eg, underreporting cannabis use) (Akinci et 
al., 2001; Delaney-Black et al., 2010). In a study by Kedzior et al, it was demonstrated that there 
is only moderate accuracy when self-reporting past-year cannabis use (Kedzior et al., 2006). 
Furthermore, there was no available information on the quantity and potency (eg, THC content) 
of cannabis consumed, although such information is challenging to quantify given the variation 
in the methods of cannabis consumption (eg, edibles v. joints), source and dosage (Gray et al., 
2009). Further, it was not possible to disentangle between cannabis use and cannabis use disorder 
in the present study. Cannabis use disorder is characterized by dependence and abuse criteria as 
well as metrics on craving and withdrawal symptoms, whereas the item used in this study could 
not ascertain such a diagnosis. It has been demonstrated that cannabis use disorder is associated 
with worse outcomes including cognitive decline as well as poorer social functioning (Hasin et 
al., 2016), which may not be the case for cannabis use per se. Therefore, it may be that similar 
findings as those found in the present study would not hold for individuals with cannabis use 
disorder and as such, future research would be warranted. Moreover, although it has been 
documented that adolescent onset of cannabis use is associated with negative mental health 
outcomes (Rioux et al., 2018; Swahn et al., 2012), poor psychosocial adjustment (Fergusson and 
Horwood, 1997) and cognitive decline (Castellanos-Ryan et al., 2017; Meier et al., 2012) in 
adulthood, the present study did not evaluate the age of onset of cannabis use and its relation to 
depressive symptoms and suicidal ideation. Second, as in our previous work with this cohort 
(Geoffroy et al., 2018), our self-report questionnaires for depression did not provide a clinical 
diagnosis and we used an arbitrary cut-off to approximate individuals with the highest symptoms 
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at each age. However, cross-lagged models were re-estimated using depressive symptoms as a 
continuous variable, and patterns of results were largely similar. Third, although items assessing 
cannabis use and suicidal ideation were the same across all time points, depression was measured 
with the MIA at ages 15 and 17 years (assessing past-year depressive symptoms) and the CES-D 
at 20 years (assessing past two-weeks depressive symptoms). However, these measures capture 
similar symptoms, standardization of cut-off increased comparability across time-points, and 
cannabis use was not associated with depression at 17 years (MIA) nor 20 years (CES-D).   
Fourth, all measures were self-reported, potentially inflating strengths of associations due to 
shared method variance. Fifth, our study is observational in nature, and despite adjustments for 
time-sensitive covariates, we cannot rule out that unmeasured covariates may have accounted for 
some associations. For instance, it has been argued that genetic factors may contribute to the 
association between cannabis use and subsequent depression and suicidal ideation (Agrawal and 
Lynskey, 2014), although such variables were not available in the present sample. Sixth, as with 
all longitudinal surveys, attrition had occurred, with the most vulnerable participants more likely 
to be lost at follow-up. Nevertheless, our weighted analyses minimized such selective attrition 
bias.  
Conclusion 
Our findings suggest that cannabis use increases throughout adolescence and that once 
this behavior is initiated, cannabis use is likely to remain stable over time. We also found 
evidence for adolescents experiencing depressive symptoms to be at a greater risk of using 
cannabis on a weekly basis later on. These findings highlight the importance of targeting 
depressive symptoms during this sensitive developmental period in an attempt to offset the 
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P-value for sex 
differencesd 
Variable 15 y 17 y 20 y  15 y 17 y 20 y  15 y 17 y 20 y  15 y 17 y 20 y 
Cannabis Use, n(%)             .282 .031 .045 
   Non-User 1097(76.3) 749(59.3) 702(56.4)  562(74.8) 407(59.6) 421(58.6) 535(78.0) 342(58.9) 281(53.4)    
   Monthly User 239(16.6) 355(28.1) 349(28.0)  136(18.1) 204(29.9) 201(28.0)  103(15.0) 151(26.0) 148(28.1)    




           <.001 <.001 .012 
   Depressed 146(10.1) 118(9.3) 137(11.1)  116(15.4) 94(13.7) 92(12.9)  30(4.4) 24(4.2) 45(8.6)     
   Non-depressed 1296(89.9) 1146(90.7) 1101(88.9) 637(84.6) 592(86.3) 621(87.1) 659(95.6) 554(95.8) 480(91.4)    
Suicidal ideation n(%)             <.001 <.001 .891 
   Suicidal ideation 86(6.0) 84(6.8) 123(10.0)  65(8.7) 61(9.1)  70(9.9)  21(3.1) 23(4.1) 53(10.1)     
   Non-suicidal ideation 1342(94.0) 1144(93.2) 1112(90.0)  682(91.3) 607(90.9) 640(90.1) 660(96.9) 537(95.9) 472(89.9)    
aData were compiled from the final master file of the Québec Longitudinal Study of Child Development (1998-2018) ©Québec Gouvernement, Institut de la 
Statistique du Québec. 
b The proportion of missing values at ages 15, 17 and 20 years for cannabis use: 35.4%, 43.1% and 44.0%, respectively; depression: 35.1%, 43.1% and 44.3%, 
respectively; and suicidal ideation: 35.8%, 44.8% and 44.4%, respectively. 
cDepression scores were categorized as ≤90th percentile (not depressed) versus >90th percentile (depressed). 
dP values are based on chi-square tests. 
Note: The Mental Health and Social Inadaptation Scale (Côté et al., 2017) and Centre for Epidemiologic Studies Depression Scale (short-form) (Poulin et al., 





Table 2. Odds ratios (ORs) and 95% confidence intervals (CIs) for cross-sectional associations of 
cannabis use with depression and suicidal ideation during adolescencea (N=1606).  
 Depression
b Suicidal Ideation  
  N(%) OR (95%CI) N(%) OR (95%CI)   
Cannabis Use      
Monthly Users      
  15 y 35(24.1) 1.99(1.28-2.97) 24(27.9) 2.60(1.53-4.31)  
  17 y 36(30.8) 1.39(0.88-2.17) 26(31.0) 1.37(0.80-2.31)  
  20 y 31(27.0) 0.97(0.61-1.52) 42(34.1) 1.66(1.13-2.72)  
Weekly Users       
  15 y  18(12.4) 2.35(1.31-4.04) 15(17.4) 3.83(1.88-7.02)  
  17 y 27(23.1) 2.56(1.54-4.19) 19(22.6) 2.39(1.32-4.21)  
  20 y 20(17.4) 1.12(0.64-1.88) 32(26.0) 2.57(1.58-4.12)   
aData were compiled from the final master file of the Québec Longitudinal Study of Child Development 
(1998-2018) ©Québec Government, Institut de la Statistique du Québec. 
bDepression scores were categorized as ≤90th percentile (not depressed) versus >90th percentile 
(depressed). 
Note: All models adjusted for sex. p for sex interaction = .459, .159, .504 for depression 15y, 17y and 
20y, respectively; and .978, .471 and .366 for suicidal ideation at 15 y, 17 y and 20 y, respectively. 
Note: The Mental Health and Social Inadaptation Scale (Côté et al., 2017) and Centre for Epidemiologic 
Studies Depression Scale (short-form) (Poulin et al., 2005a; Radloff, 1977) were used to assess 
depression, however, these measures did not provide clinical diagnoses of depression, but rather assessed 















Depression subscale from Mental Health and Social Inadaptation Assessment for 
Adolescents (MIA); 8 items; 15 and 17 years  
Nothing was fun for me, I wasn't interested in anything. 
I felt sad and unhappy. 
I lacked energy or felt tired. 
I lost interest in things I usually like. 
I felt I couldn't do anything well. 
I felt I wasn't as good-looking or as smart as other people. 
Doing even little things made me feel really tired. 
I had trouble thinking clearly. 
 
Center for Epidemiologic Studies Depression Scale (CES-D); 13 items; 20 years 
I did not feel like eating; my appetite was poor. 
I felt that I could not shake off the blues even with help from my family or friends. 
I had trouble keeping my mind on what I was doing.  
I felt depressed.  
I felt that everything I did was an effort.   
I felt hopeful about the future.  
My sleep was restless. 
I was happy. 
I felt lonely. 
I enjoyed life. 
I had crying spells. 
I felt that people disliked me.  









Table S1. Sociodemographic Characteristics of Participants Versus Non-Participantsa 





Child Sex, N(%)        <.001 
  Male     769(47.9)  203(39.5)   
Socioeconomic status, mean (SD)c 0.06(.99)  0.21(.99)  .346 
Maternal education, N(%)        
  No high school diploma   269(16.8)  116(22.6)  .003 
Maternal age at child birth, mean (SD) 29.39(5.15)  28.98(5.44)  .072 
Family composition, N(%)      .024 
  Biological parents   1304(81.2)  402(78.2)   
  Single parent   114(7.1)  57(11.1)   
  Blended    183(11.4)  52(10.1)   
Maternal depressiond, mean (SD) 0.99(.94)  1.03(1.03)  .296 
Child externalizing behavioure (up to age 6), 
mean (SD) 
2.73(1.60)  2.63(1.23)  .149 
Child internalizing behavioure (up to age 6), 
mean (SD) 
1.32(.96)  1.11(1.01)  <.001 
aVariables were measures when the child was 5 months of age, otherwise indicated. Data were compiled from the 
final master file of the Québec Longitudinal Study of Child Development (1998-2018), ©Québec Government, 
Québec Statistics Institute. 
bp-values are based on independent t test for continuous variables and chi-square test for 
categorical variables. 
  
cAssessed with an aggregate of 5 items regarding parental educational level, parental occupation, and annual 
gross income (range, -3 to 3, centered at 0, with higher scores indicating higher socioeconomic status)1. 
dAssessed using a short version of the Center for Epidemiological Study Depression Scale 2. Scores range from 0 
to 10, with higher scores indicating higher depressive symptoms.  
eAssessed using the Children's Social Behaviour Questionnaire (reported by mothers)3.  Scores range from 0 to 






Table S2. Cross-tabulation of cannabis and other substance use at ages 15, 17 and 20 yearsa,b   
Cannabis Use, n(%) 
 15 years  17 years  20 years 












Weekly    
User 
p-value 
Alcohol, n(%)               
   Non-Users 537(49) 17(7.1%) 2(2.0)  < .001  198(26.9) 7(2.0) 3(1.9)  < .001  121(17.3) 9(2.6) 11(5.7)  < .001 
   Monthly Users 519(47.4) 195(81.6) 65(64.4)  < .001  466(63.4) 243(68.5) 88(55.0)  < .001  511(73.0) 266(76.2) 121(62.4)  < .001 
   Weekly Users 40(3.6) 27(11.3) 34(33.7)  < .001  71(9.7) 105(29.6) 69(43.1)  < .001  68(9.7) 74(21.2) 62(32.0)  < .001 
Tobacco, n(%)               
   Non-Users 1079(98.7) 211(88.7) 52(51.5)  < .001  728(97.5) 320(90.9) 77(48.1)  < .001  631(90.1) 241(69.1) 68(35.1)  < .001 
   Monthly Users 2(0.2) 9(3.8) 8(7.9)  < .001  3(0.4) 12(3.4) 21(13.1)  < .001  37(5.3) 69(19.8) 49(25.3)  < .001 
   Weekly Users 12(1.1) 18(7.6) 41(40.6)  < .001  16(2.1) 20(5.7) 62(38.8)  < .001  32(4.6) 39(11.2) 77(39.7)  < .001 
Other Drug Use, n(%)              
   Yes 7(0.6) 34(14.3) 47(47.0)  < .001  4(0.5) 54(15.5) 82(51.6)  < .001  19(2.7) 69(19.8) 97(50.0)  < .001 
   No  1090(99.4) 203(85.7) 53(53.0)   745(99.5) 295(84.5) 77(48.4)   683(97.3) 280(80.2) 97(50.0)  
aData were compiled from the final master file of the Québec Longitudinal Study of Child Development (1998-2018) ©Québec Government, Institut de la Statistique du Québec. 
bSample size was N = 1606 based on participants included in the longitudinal analyses.         
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